ONDANSETRON Labatec conc perf 4 mg/2ml 5 amp 2 ml
7680594350014
CH-59435
A04AA01
01.09.0.
Reimbursement limitations:
EMETCHEMOTHE
Chimiothérapie fortement émétogène.
1 / 2
google
Details
- Product number
- 5943501
- CPT
- -
- Packaging group
- 5x2ml
- Unit
- Ampulle(n)
- Composition
- ondansetronum 4 mg ut ondansetroni hydrochloridum dihydricum, natrii chloridum, acidum citricum monohydricum, natrii citras dihydricus, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 7.2 mg.
Articles (1)
Ondansetron Labatec, 4mg/2ml, concentré pour perfusion
Infusionskonzentrat
5x2ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.2 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 50.00
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2018
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59435
- Drug name
- Ondansetron Labatec, concentré pour perfusion
- Galenic form
- KOIN
- ATC Code
- A04AA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/02/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONDANSETRON Labatec conc perf 4 mg/2ml 5 amp 2 ml
- Description (DE)
- ONDANSETRON Labatec Inf Konz 4 mg/2ml 5 Amp 2 ml
- Market launch
- 03/02/2010
- Narcotic (BTM)
- No